Dublin, April 01, 2025 (GLOBE NEWSWIRE) -- The "Needle Free Diabetes Care Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ResearchAndMarkets.com's offering.
The global Needle-Free Diabetes Care market was valued at USD 13.51 billion in 2024 and is expected to experience significant growth during the forecast period, with a projected compound annual growth rate (CAGR) of 5.90% through 2030.
Key Market Driver: Rising Prevalence of Diabetes
The increasing prevalence of diabetes is largely driven by factors such as sedentary lifestyles, poor dietary habits, and an aging population. This growing global health concern not only impacts individual health but also places a substantial strain on healthcare systems and economies. According to the World Health Organization (WHO), diabetes is a chronic condition characterized by elevated blood glucose levels, which can lead to severe complications.
Over 830 million people worldwide are affected by diabetes, with a significant proportion living in low- and middle-income countries. Diabetes management is shifting from a physician-centered model to a more patient-centric approach. Patients now seek solutions that offer greater convenience, reduce pain, and improve their quality of life. As traditional insulin injections are often seen as uncomfortable and inconvenient, there is an increasing demand for needle-free alternatives.
Key Market Challenge: Regulatory Approvals
One of the key challenges in the needle-free diabetes care market is the need for regulatory approvals for new devices and technologies. Regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) impose strict safety and efficacy standards, making the approval process time-consuming and costly for manufacturers. These regulatory hurdles can delay the introduction of new products into the market.
Key Market Trend: Closed-Loop Systems
Closed-loop insulin delivery systems, often referred to as artificial pancreases, are gaining popularity in the diabetes care market. These systems automatically adjust insulin delivery based on continuous glucose monitoring (CGM) data, providing users with better control over their blood glucose levels. As technology continues to evolve, closed-loop systems are expected to become more accessible, user-friendly, and effective.
Key Players in the Needle Free Diabetes Care Market:
- 3M Co.
- Bioject Medical Technologies Inc.
- Valeritas Inc.
- Antares Pharma Inc.
- Endo International PLC
- InsuJet
- PharmaJet Inc.
- INJEX Pharma AG
- Johnson & Johnson
- MannKind Corp.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 180 |
| Forecast Period | 2024-2030 |
| Estimated Market Value (USD) in 2024 | $13.51 Billion |
| Forecasted Market Value (USD) by 2030 | $18.9 Billion |
| Compound Annual Growth Rate | 5.9% |
| Regions Covered | Global |
Key Topics Covered
1. Product Overview
2. Research Methodology
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Needle Free Diabetes Care Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Device Type (Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps, Jet Injectors)
5.2.2. By End User (Homecare, Diagnostic Center, Hospitals & Clinic)
5.2.3. By Region
5.2.4. By Company (2024)
5.3. Product Market Map
5.3.1. By Device Type
5.3.2. By End User
5.3.3. By Region
6. North America Needle Free Diabetes Care Market Outlook
7. Europe Needle Free Diabetes Care Market Outlook
8. Asia-Pacific Needle Free Diabetes Care Market Outlook
9. South America Needle Free Diabetes Care Market Outlook
10. Middle East and Africa Needle Free Diabetes Care Market Outlook
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. Porter's Five Forces Analysis
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products
14. Competitive Landscape
14.1. 3M Co.
14.2. Bioject Medical Technologies Inc.
14.3. Valeritas Inc.
14.4. Antares Pharma Inc.
14.5. Endo International PLC
14.6. InsuJet
14.7. Pharmajet Inc.
14.8. INJEX Pharma AG
14.9. Johnson & Johnson
14.10. MannKind Corp.
15. Strategic Recommendations
For more information about this report visit https://www.researchandmarkets.com/r/mnmh2r
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
